Sexual Dysfunction

Results of a single-institution study support the long-term safety and efficacy of testosterone replacement therapy for treating hypogonadism in men who have undergone radical prostatectomy.

This month's round-up of new products includes CIVCO patient drapes, MediSafe Projects' medication alert app, a direct purchase program for Zoladex, and GAMMEX non-latex-sensitive surgical gloves.

Testosterone, a hormone somewhat relegated to background status for many years, is moving to the fore as a central factor in men's health and disease.

Testosterone replacement therapy (TRT) did not increase the risk of biochemical recurrence in hypogonadal men with localized prostate cancer.

Having a positive attitude regarding active surveillance for patients with low-risk prostate cancer does not correlate with the likelihood that radiation oncologists and urologists will recommend it in lieu of treatment.

Testosterone replacement therapy may result in weight reduction and improvement in symptoms of metabolic syndrome, according to separate studies presented at the Endocrine Society annual meeting in Houston.